Paclitaxel is a microtubule-stabilizing chemotherapeutic agent used in ovarian and breast cancer; its principal adverse effect is sensory neuropathy. We describe the occurrence of sensory polyneuropathy after multiple paclitaxel-eluting stents in a patient who may have sub-clinical Sjogrens syndrome.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jns.2009.02.342 | DOI Listing |
Publication Analysis
Top Keywords
sensory polyneuropathy
8
polyneuropathy associated
4
associated paclitaxel-eluting
4
paclitaxel-eluting coronary
4
coronary stent
4
stent paclitaxel
4
paclitaxel microtubule-stabilizing
4
microtubule-stabilizing chemotherapeutic
4
chemotherapeutic agent
4
agent ovarian
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!